Addressing new post-pandemic threats
A worldwide health concern
After the pandemic, a new threat rose for the survivors of SARS-CoV-2 infection: 4 to 20% of infected people developed a syndrome called post-acute sequelae of COVID (PASC). The most common symptoms include respiratory, neurological, cardiovascular, thrombotic and cerebrovascular manifestations, with many of those affected unable to return to work.
PASC is associated with all ages and can occur after mild, moderate or severe forms of the disease. This poses a public health threat and an important burden to societies and healthcare systems. With no diagnostic biomarkers or effective treatments available, there is an urgent need of research to understand, prevent, and develop measures to mitigate the effects of PASC.